2025 Fall MCELLBI 120L 001 LEC 001

2025 Fall

MCELLBI 120L 001 - LEC 001

Therapeutics Discovery Laboratory

Ross C Wilson, Roberto Zoncu

Aug 27, 2025 - Dec 12, 2025
Tu, Th
12:30 pm - 12:59 pm
Class #:34140
Units: 4

Instruction Mode: In-Person Instruction

Offered through Molecular and Cell Biology

Current Enrollment

Total Open Seats: 0
Enrolled: 24
Waitlisted: 0
Capacity: 24
Waitlist Max: 0
No Reserved Seats

Hours & Workload

1 hours of instructor presentation of course materials per week, 3 hours of outside work hours per week, and 8 hours of instructional experiences requiring special laboratory equipment and facilities per week.

Final Exam

FRI, DECEMBER 19TH
08:00 am - 11:00 am
Stanley 177

Other classes by Ross C Wilson

Other classes by Roberto Zoncu

Course Catalog Description

This lab course will familiarize students with general principles of drug discovery and action. The first module focuses on aspects of small molecule function by comparing stoichiometric inhibitors and PROTAC molecules against the BTK kinase. Students will learn how to purify protein, monitor drug binding and in vitro efficiency, and determine effects on cell survival. The second module focuses on genomic therapies by introducing students to principles of CRISPR genome editing. Students will design genome editing strategies and cognate guide RNAs and then perform an editing experiment that replaces a catalytic Cys residue in BTK with Ser. Students will compare stoichiometric inhibitors against BTK to PROTAC in wildtype or mutant cells.

Rules & Requirements

Repeat Rules

Course is not repeatable for credit.

Reserved Seats

Reserved Seating For This Term

Current Enrollment

No Reserved Seats

Terms in Attendance:
Undergraduate Classifications Information

Textbooks & Materials

See class syllabus or https://calstudentstore.berkeley.edu/textbooks for the most current information.

Textbook Lookup

Guide to Open, Free, & Affordable Course Materials

eTextbooks

Associated Sections